Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Cancers (Basel) · 2020 · PMC7795942 · PMID 33396187

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

closely significantno p-value reported

Biomarkers who presented with significant or closely significant p -values were then tested in a second step with regards to clinical benefit.

also in 33 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.